These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15249500)

  • 1. Protective role for interferon-beta in coxsackievirus B3 infection.
    Deonarain R; Cerullo D; Fuse K; Liu PP; Fish EN
    Circulation; 2004 Dec; 110(23):3540-3. PubMed ID: 15249500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-30a Modulates Type I Interferon Responses to Facilitate Coxsackievirus B3 Replication
    Li J; Xie Y; Li L; Li X; Shen L; Gong J; Zhang R
    Front Immunol; 2020; 11():603437. PubMed ID: 33519812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice.
    Glück B; Schmidtke M; Merkle I; Stelzner A; Gemsa D
    J Mol Cell Cardiol; 2001 Sep; 33(9):1615-26. PubMed ID: 11549341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CX3CR1 knockout aggravates Coxsackievirus B3-induced myocarditis.
    Müller I; Pappritz K; Savvatis K; Puhl K; Dong F; El-Shafeey M; Hamdani N; Hamann I; Noutsias M; Infante-Duarte C; Linke WA; Van Linthout S; Tschöpe C
    PLoS One; 2017; 12(8):e0182643. PubMed ID: 28800592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis.
    Schmidtke M; Glück B; Merkle I; Hofmann P; Stelzner A; Gemsa D
    J Med Virol; 2000 Aug; 61(4):518-26. PubMed ID: 10897072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.
    Jenke A; Holzhauser L; Löbel M; Savvatis K; Wilk S; Weithäuser A; Pinkert S; Tschöpe C; Klingel K; Poller W; Scheibenbogen C; Schultheiss HP; Skurk C
    Basic Res Cardiol; 2014 May; 109(3):408. PubMed ID: 24691762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression analysis during recovery process indicates the mechanism for innate immune injury and repair from Coxsackievirus B3-induced myocarditis.
    Yao HL; Song J; Sun P; Song QQ; Sheng LJ; Chi MM; Han J
    Virus Res; 2016 Feb; 213():314-321. PubMed ID: 26779987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo ablation of type I interferon receptor from cardiomyocytes delays coxsackieviral clearance and accelerates myocardial disease.
    Althof N; Harkins S; Kemball CC; Flynn CT; Alirezaei M; Whitton JL
    J Virol; 2014 May; 88(9):5087-99. PubMed ID: 24574394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis.
    Weithauser A; Bobbert P; Antoniak S; Böhm A; Rauch BH; Klingel K; Savvatis K; Kroemer HK; Tschope C; Stroux A; Zeichhardt H; Poller W; Mackman N; Schultheiss HP; Rauch U
    J Am Coll Cardiol; 2013 Nov; 62(19):1737-45. PubMed ID: 23871888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-beta expression and type I interferon receptor signaling of hepatocytes prevent hepatic necrosis and virus dissemination in Coxsackievirus B3-infected mice.
    Koestner W; Spanier J; Klause T; Tegtmeyer PK; Becker J; Herder V; Borst K; Todt D; Lienenklaus S; Gerhauser I; Detje CN; Geffers R; Langereis MA; Vondran FWR; Yuan Q; van Kuppeveld FJM; Ott M; Staeheli P; Steinmann E; Baumgärtner W; Wacker F; Kalinke U
    PLoS Pathog; 2018 Aug; 14(8):e1007235. PubMed ID: 30075026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
    Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
    Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production.
    Liu H; Li M; Song Y; Xu W
    Front Immunol; 2018; 9():2479. PubMed ID: 30410495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production.
    Fuse K; Chan G; Liu Y; Gudgeon P; Husain M; Chen M; Yeh WC; Akira S; Liu PP
    Circulation; 2005 Oct; 112(15):2276-85. PubMed ID: 16216974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIF is a critical survival factor in viral cardiomyopathy.
    Riad A; Westermann D; Zietsch C; Savvatis K; Becher PM; Bereswill S; Heimesaat MM; Lettau O; Lassner D; Dörner A; Poller W; Busch M; Felix SB; Schultheiss HP; Tschöpe C
    J Immunol; 2011 Feb; 186(4):2561-70. PubMed ID: 21239721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major Group-B Enterovirus populations deleted in the noncoding 5' region of genomic RNA modulate activation of the type I interferon pathway in cardiomyocytes and induce myocarditis.
    Callon D; Glenet M; Lebreil AL; Heng L; Bouland N; Fichel C; Fornes P; Andreoletti L; Berri F
    PLoS Pathog; 2024 May; 20(5):e1012125. PubMed ID: 38696536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astragaloside IV exerts antiviral effects against coxsackievirus B3 by upregulating interferon-gamma.
    Zhang Y; Zhu H; Huang C; Cui X; Gao Y; Huang Y; Gong W; Zhao Y; Guo S
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):190-5. PubMed ID: 16495755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral effects of interferon-β are enhanced in the absence of the translational suppressor 4E-BP1 in myocarditis induced by Coxsackievirus B3.
    Burke JD; Sonenberg N; Platanias LC; Fish EN
    Antivir Ther; 2011; 16(4):577-84. PubMed ID: 21685545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coxsackievirus B3-induced myocarditis in MHC class II-deficient mice.
    Leipner C; Borchers M; Merkle I; Stelzner A
    J Hum Virol; 1999; 2(2):102-14. PubMed ID: 10225212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis.
    Henke A; Huber S; Stelzner A; Whitton JL
    J Virol; 1995 Nov; 69(11):6720-8. PubMed ID: 7474082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A non-cardiovirulent strain of coxsackievirus B3 causes myocarditis in mice with severe combined immunodeficiency syndrome.
    Hufnagel G; Chapman N; Tracy S
    Eur Heart J; 1995 Dec; 16 Suppl O():18-9. PubMed ID: 8682092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.